Board has considered and adopted Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March,2026 and Recommended 15% dividend for the financial year 2025-26
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Crestchem Ltd's board approved the audited standalone and consolidated financial results for FY 2025-26 ending March 31, 2026. Profit for the year grew to Rs 375.74 Lacs from Rs 365.68 Lacs in the previous year. Operating cash flow improved significantly to Rs 359.22 Lacs from Rs 166.17 Lacs in the prior year. Total assets stood at Rs 1,628.92 Lacs (standalone) and Rs 1,623.92 Lacs (consolidated). The board recommended a final dividend of Rs 1.50 per share (15%) for FY 2025-26, subject to shareholder approval at the 34th AGM. Additionally, the company formed a new subsidiary Oleo Biosciences Private Limited (75% owned) at Bangalore, which has not commenced commercial operations yet.
Positive for shareholders as the company reported profit growth and significantly improved cash flows. The 15% dividend declaration provides direct returns. The new subsidiary formation indicates strategic diversification intent.